Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

plasma-derived FVIII/VWF concentrate

Plasma-derived product · Protein replacement · developed by Grifols Therapeutics LLC

Phase 4 Most advanced trial (none active)
GRFS Developer
1 Registered trials

What is plasma-derived FVIII/VWF concentrate?

Fanhdi is a plasma-derived concentrate containing factor VIII and von Willebrand factor, dosed by VWF ristocetin cofactor activity (VWF:RCo). It is studied in von Willebrand disease, a bleeding disorder caused by deficiency of VWF.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Fanhdi
Drug type
Plasma-derived product
Mechanism
Protein replacement
Therapy area
Hematology
Developer
Grifols Therapeutics LLC (GRFS)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 4

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02472665 Phase 4 Von Willebrand Disease Withdrawn GRFS

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Von Willebrand Disease

More from Grifols Therapeutics LLC

albumin human, USP FDA approved Antithrombin III FDA approved factor VIII / von Willebrand factor FDA approved Alpha-1 Phase 3 C19-IG Phase 3 Fibrin Sealant Grifols Phase 3 GRF312 Phase 2 Human Plasma-Derived Fibrinogen Concentrate Phase 1/2 IVIG-PEG Phase 3

Sources

Updated Oct 11, 2026. Something wrong or missing? Report it on the GRFS page.

Follow GRFS, the company behind plasma-derived FVIII/VWF concentrate

See GRFS's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

GRFS catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.